In the News December 10, 2019

Law360 | Clinical Biopharma Sienna OK’d to Sell IP in Ch. 11

Philippe Bennett and Walter Scott are noted for representing Sebacia Inc. in its purchase of some of Sienna Biopharmaceutical Inc.’s intellectual property.
Media Contact
Nicholas Clarke
Senior Communications Manager
Phone: 212.210.1222

This website uses cookies to improve functionality and performance. For more information, see our Privacy Statement. Additional details for California consumers can be found here.